These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 19899414)
1. The role of endothelin-1 and its correlation with CA125 levels, grayscale ultrasonography and doppler findings in differential diagnoses of ovarian tumors. Moszynski R; Szpurek D; Michalak S; Szubert S; Sajdak S Eur J Gynaecol Oncol; 2009; 30(5):552-6. PubMed ID: 19899414 [TBL] [Abstract][Full Text] [Related]
2. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements. Czekierdowski A Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913 [TBL] [Abstract][Full Text] [Related]
3. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA125 level in women with a pelvic mass. Mousavi AS; Borna S; Moeinoddini S Int J Gynecol Cancer; 2006; 16 Suppl 1():92-8. PubMed ID: 16515574 [TBL] [Abstract][Full Text] [Related]
4. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses. Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587 [TBL] [Abstract][Full Text] [Related]
5. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125. Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205 [TBL] [Abstract][Full Text] [Related]
6. CA125 and HE4: Measurement Tools for Ovarian Cancer. Zhao T; Hu W Gynecol Obstet Invest; 2016; 81(5):430-5. PubMed ID: 27160726 [TBL] [Abstract][Full Text] [Related]
7. Clinical application of HE4 and CA125 in ovarian cancer type I and type II detection and differential diagnosis. Gąsiorowska E; Michalak M; Warchoł W; Lemańska A; Jasiński P; Spaczyński M; Nowak-Markwitz E Ginekol Pol; 2015 Feb; 86(2):88-93. PubMed ID: 25807831 [TBL] [Abstract][Full Text] [Related]
8. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital]. Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203 [TBL] [Abstract][Full Text] [Related]
9. The Diagnostic Value of Transvaginal Sonograph (TVS), Color Doppler, and Serum Tumor Marker CA125, CEA, and AFP in Ovarian Cancer. Zhang F; Zhang ZL Cell Biochem Biophys; 2015 Jun; 72(2):353-7. PubMed ID: 25582421 [TBL] [Abstract][Full Text] [Related]
10. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors]. Smoleń A; Stachowicz N; Czekierowski A; Kotarski J Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596 [TBL] [Abstract][Full Text] [Related]
11. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer. Shen Y; Li L Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer. Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570 [TBL] [Abstract][Full Text] [Related]
13. Preoperative measurement of serum C-reactive protein: is it useful in the differential diagnosis of adnexal masses? Yoshida A; Derchain SF; Pitta DR; Crozatti N; Andrade LALA; da Silva RF; Sarian LO Int J Biol Markers; 2017 Mar; 32(1):e83-e89. PubMed ID: 27516000 [TBL] [Abstract][Full Text] [Related]
14. Doppler flow and arterial location in ovarian tumors. Itakura T; Kikkawa F; Kajiyama H; Mitsui T; Kawai M; Mizutani S Int J Gynaecol Obstet; 2003 Dec; 83(3):277-83. PubMed ID: 14643038 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer. Kristjansdottir B; Levan K; Partheen K; Sundfeldt K Gynecol Oncol; 2013 Oct; 131(1):52-8. PubMed ID: 23891789 [TBL] [Abstract][Full Text] [Related]
16. Better Predictive Value of Cancer Antigen125 (CA125) as Biomarker in Ovary and Breast Tumors and its Correlation with the Histopathological Type/Grade of the Disease. Nazmeen A; Maiti S; Mandal K; Roy SK; Ghosh TK; Sinha NK; Mandal K Med Chem; 2017; 13(8):796-804. PubMed ID: 28440189 [TBL] [Abstract][Full Text] [Related]
17. HE4, CA125, the Risk of Malignancy Algorithm and the Risk of Malignancy Index and complex pelvic masses - a prospective comparison in the pre-operative evaluation of pelvic masses in an Australian population. Richards A; Herbst U; Manalang J; Pather S; Saidi S; Tejada-Berges T; Tan K; Williams P; Carter J Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):493-7. PubMed ID: 26172511 [TBL] [Abstract][Full Text] [Related]
18. Estimation of the usefulness of neoplastic markers TPS and CA 125 in diagnosis and monitoring of ovarian cancer. Zygmunt A; Madry R; Markowska J; Fischer Z Eur J Gynaecol Oncol; 1999; 20(4):298-301. PubMed ID: 10475127 [TBL] [Abstract][Full Text] [Related]
19. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients. Li QL; Wang CJ; Qi P; Zhang YX Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641 [TBL] [Abstract][Full Text] [Related]
20. [Assessment of ultrasonography markers and CA125 usefulness in the diagnosis of ovarian cysts]. Szczublewski P; Szpurek D; Moszyński R; Szubert S; Sajdak S Ginekol Pol; 2008 Dec; 79(12):856-61. PubMed ID: 19175043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]